Cirozė klinikiniai tyrimai Texas
13 tyrimai dėl Cirozė ieško dalyvių vietose Texas.
Miestai Texas
Oficialus tyrimo tekstas (anglų kalba)
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Texas Clinical Research Institute, LLC, Arlington
- IMA Clinical Research Austin, Austin
- American Research Corporation - Austin, Austin
- ir dar 35
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06632444A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
- Texas Clinical Research Institute, LLC, Arlington
- Epic Medical Research - Carrollton, Carrollton
- The Liver Institute at Methodist Dallas, Dallas
- ir dar 5
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-30 · NCT07325526National Liver Cancer Screening Trial
- UT Southwestern Medical Center and Parkland Hospital, Dallas
- Baylor College of Medicine, Houston
Renkami dalyviai4 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06084234Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
- Research Site, Austin
- Research Site, Denison
- Research Site, Georgetown
- ir dar 4
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-01 · NCT07610837Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Liver Center of Texas, Dallas
- Methodist Hospital, Richardson
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-10 · NCT05181826Multi-analyte Blood Test Clinical Trial
- South Texas Research Institute, Edinburg
- Texas Gastro Research, El Paso
- Impact Research Institute, Waco
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-10 · NCT05199259High Dose Albumin in Refractory Ascites
- Baylor St' Lukes Medical center, Houston
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-30 · NCT05867602Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis
- UT Health San Antonio, San Antonio
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-01-06 · NCT06526104Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- Baylor College of Medicine (Scott & White), Dallas
- Michael E DeBakey VA Medical Center, Houston
- Baylor St. Luke's Medical Centre, Houston
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2025-10-20 · NCT04613921Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
- University of Texas Southwestern Medical Center, Dallas
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-09-23 · NCT05028829EGCG for Hepatocellular Carcinoma Chemoprevention
- UT Southwestern, Dallas
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-09-05 · NCT06015022Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
- Methodist Health System, Dallas Medical Center, Dallas
- VA North Texas Healthcare System, Dallas
- Texas Liver Institute, San Antonio
Renkami dalyviai1 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2025-09-05 · NCT05490888Evaluation of Non-Invasive Tests for Metabolic Liver Disease
- First Surgical Hospital, Bellaire
- Endeavor Clinical Trials, San Antonio
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2025-08-14 · NCT07122700Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.